Cargando…

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma

Recently, a genome-wide association study showed that a single nucleotide polymorphism (SNP) —rs11706832—in intron 2 of the human LRIG1 (Leucine-rich repeats and immunoglobulin-like domains 1) gene is associated with susceptibility to glioma. However, the mechanism by which rs11706832 affects glioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Feng, Holmlund, Camilla, Faraz, Mahmood, Wang, Wanzhong, Bergenheim, Tommy, Kvarnbrink, Samuel, Johansson, Mikael, Henriksson, Roger, Hedman, Håkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833707/ https://www.ncbi.nlm.nih.gov/pubmed/29391393 http://dx.doi.org/10.1038/s41389-017-0012-8

Ejemplares similares

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors
por: Faraz, Mahmood, et al.
Publicado: (2018)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer
por: Faraz, Mahmood, et al.
Publicado: (2020)

LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes
por: Herdenberg, Carl, et al.
Publicado: (2021)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
por: Thomasson, Marcus, et al.
Publicado: (2012)

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2009)

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma
por: Johansson, M, et al.
Publicado: (1999)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000)

HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
por: Herdenberg, Carl, et al.
Publicado: (2022)

Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014)

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
por: Wibom, C, et al.
Publicado: (2006)

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
por: Wibom, C, et al.
Publicado: (2006)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–RCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2004)

Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder
por: Roberts, Neil A., et al.
Publicado: (2019)

LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance
por: Billing, Ola, et al.
Publicado: (2021)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas
por: Mörén, Lina, et al.
Publicado: (2016)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information
por: Mörén, Lina, et al.
Publicado: (2015)

DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.
por: Vallbo, C., et al.
Publicado: (1995)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy
por: Heinrichs, Stefan, et al.
Publicado: (2013)

Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway
por: Yang, Hong-Kuan, et al.
Publicado: (2017)

The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model
por: Sandström, M, et al.
Publicado: (2004)

Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study
por: Tabatabaei, Pedram, et al.
Publicado: (2016)

Conditional haploinsufficiency of the retinoblastoma tumor suppressor gene
por: Ishak, Charles A, et al.
Publicado: (2014)

EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma
por: Wibom, Carl, et al.
Publicado: (2012)

Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma
por: Björkblom, Benny, et al.
Publicado: (2019)

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Li, Qiuhui, et al.
Publicado: (2019)

LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor
por: Ji, Yibing, et al.
Publicado: (2022)

LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma
por: Peng, Chenghao, et al.
Publicado: (2021)

PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
por: Wartewig, Tim, et al.
Publicado: (2017)

LRIG1-2 and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPV-DNA and p16(INK4a) status
por: Stefansson, Kristina, et al.
Publicado: (2019)

Reproducibility and geometric accuracy of the fixster system during hypofractionated stereotactic radiotherapy
por: Lindvall, Peter, et al.
Publicado: (2008)

Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth
por: Li, Youwei, et al.
Publicado: (2023)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_md1hnl7d6tvnsccomhrqrr7uq8